In an era of genetic testing, advanced imaging, and multi-cancer blood tests, the single most cost-effective tool for identifying who needs closer surveillance is also the oldest one: a carefully taken family history. It costs nothing. It takes 20 minutes. And it changes clinical management in roughly 30% of patients.

Why three generations matter

A useful family history covers three generations: parents, siblings, children, and all four grandparents. For each relative, the critical information is: what diseases did they develop, and at what age? The age of onset is often more important than the diagnosis itself.

A father who had a heart attack at age 72 suggests age-related cardiovascular disease — concerning but expected. A father who had a heart attack at age 48 suggests a heritable lipid disorder, possibly familial hypercholesterolemia, and completely changes the risk stratification for every first-degree relative.

Similarly: colorectal cancer at 75 is common. Colorectal cancer at 42 raises the question of Lynch syndrome — a hereditary condition that affects 1 in 279 people and dramatically increases risk of colon, endometrial, ovarian, and other cancers. First-degree relatives of Lynch carriers need colonoscopy starting at 20–25, not 45.

What family history changes in practice

  • Cardiovascular disease in a first-degree relative before 55 (men) or 65 (women): Reclassifies the patient to higher cardiovascular risk. Triggers ApoB and Lp(a) measurement (both in our DETECT panel). May indicate familial hypercholesterolemia — which affects 1 in 250 people and is dramatically undertreated.
  • Colorectal cancer before 50 in a first-degree relative: Start colonoscopy 10 years before the relative's age of diagnosis (or at 40, whichever is earlier). Consider genetic testing for Lynch syndrome.
  • Breast/ovarian cancer before 50, or multiple cases: Consider BRCA testing. If positive, screening and risk-reduction strategies change fundamentally.
  • Type 2 diabetes in parents: Doubles the patient's lifetime diabetes risk. Strengthens the case for HOMA-IR monitoring and early lifestyle intervention.
  • Multiple cancers in the family before age 50: Raises suspicion for hereditary cancer syndrome. May warrant WB-MRI screening (one of the few clinical scenarios where we offer it).

The problem

Most annual physicals don't take a proper family history. The physician asks "any family history of heart disease or cancer?" — a yes/no question that captures almost nothing useful. Our digital intake questionnaire asks about each first-degree and second-degree relative individually, with specific questions about diagnosis type and age of onset. The Quarterback Physician reviews this 2–3 weeks before your arrival and uses it to pre-plan your PROTECT modules.

Before you come to Munich, do your homework: call your parents, siblings, and any living grandparents. Ask what conditions they've been diagnosed with and at what age. This 20-minute phone call may be the most valuable thing you do for your own health — because it tells us where to look hardest.

References

  1. Guttmacher AE, et al. Genomic medicine — a primer. N Engl J Med. 2002;347(19):1512-1520.
  2. Win AK, et al. Prevalence and penetrance of major genes and polygenes for colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2017;26(3):404-412.
  3. Nordestgaard BG, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated. Eur Heart J. 2013;34(45):3478-3490.